INTRODUCTION
Immune hemolytic anemia may be associated with complement fixation and direct intravascular hemolysis may result. If lysis does not occur, complement components may accumulate on the membranes of unlysed cells (1, 2) . The fourth component (C4), the third component (C3), and the fifth component of complement (C5) have been shown to be attached in vivo to the red blood cells of some patients with immune hemolytic anemia (3) . Of these components, C3 is attached in large amounts and its presence on the membrane is largely responsible for (4) . In the present paper, we describe a method for measuring membrane-bound C3 which is based on the fixation of the first component of complement (Cl) by a rabbit anti-human C3 antibody reacting with membranebound C3. The amount of C1 fixed to red cell-C3-anti-C3 complexes was measured by the method of Borsos and Rapp (5) and the relationship of the amount of Cl fixed to the amount of C3 bound was established.
The cold agglutinin syndrome provides an opportunity to study the consequences of attachment of complement to the membrane. Large amounts of C3 are fixed to the red cells but the antibody is readily dissociated from the membrane by warming (6) . Thus it is possible to examine the C3 attached to the membrane without interference by the presence of antibody.
Using the anti-C3-Cl fixation and transfer technique, we have examined the binding of C3 to red cells in patients with the cold agglutinin syndrome, and the relationship of bound C3 to the destruction of the cells. It is apparent from these studies that most of the C3 which is detected on the membrane in the absence of cold stress is hemolytically ineffective. With cold stress, C3 is rapidly added in large amounts and increased hemolysis results. The rate of addition of C3 to the membrane appears to be important, since even larger amounts may be fixed slowly without hemolytic consequences.
METHODS
Red blood cells and serum. Blood was collected in EDTA from patients with cold agglutinin disease and the red cells were immediately separated and washed at 37°C. Serum from these patients was obtained by collecting blood and maintaining it at 37°C until the clot had retracted. The serum was then removed, incubated at 56°C for 30 min and frozen at -200C.
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Blood from normal donors was collected in an equal volume of Alsever's solution (7) and stored at 40C until the time of use. "Standard" suspensions of red cells containing 2.2 X 10' cells/cm3 were made as in reference 8. To obtain normal human serum as a source of complement, blood, drawn aseptically was immediately cooled and centrifuged at 0°C. The plasma was removed and was maintained at room temperature until a fibrin clot was formed, which was removed. The serum was then frozen at -90'C until use.
Buffers and complement reagents. Veronal-buffered saline (VBS),' isotonic sucrose buffer, 60%o isotonic sucrose-40% VBS ("60% sucrose") buffer, and buffered 0.015 M ethylenediamine-tetraacetic acid disodium salt (EDTA) were prepared according to the methods outlined in reference 9. Sheep red cells, rabbit antibody to boiled sheep red cell stroma, guinea pig serum as a source of complement, the first (Cl) and second (C2) components of complement, and sensitized sheep cells with the fourth component of complement (C4) on the surface (EAC4) were prepared as previously described (9, 10) .
C3 and anti-C3. Human C3 was purified by a modification of the method of Nilsson and Muller-Eberhard (11) . A euglobulin precipitate of fresh human serum was applied to a DEAE column equilibrated with 0.03 M pH 8.1 phosphate buffer and eluted with a gradient from 0.03 M phosphate buffer, pH 8.1 to 0.2 M NaH2PO4. The C3-containing fractions detected by immunoprecipitation were applied in a batch technique to hydroxyapatite which had been equilibrated with 8 m mho phosphate buffer pH 7.9, the hydroxyapatite was then washed with 12 and 13 m mho phosphate buffer pH 7.9 and the C3-containing material was eluted with 14.5 m mho phosphate buffer. The C3-containing supernatant fluid was then concentrated by the method of Alper and Rosen (12) . The ,81c, ,B1A, and a2D arcs were present, and spurring of the jic arc beyond the 81A arc indicated the presence of antibodies to antigens present on 8,c which were not detectable on 8lA. 5 Nearly all the anti-C3 activity was found in the IgG-containing fractions; only trace amounts were present in the exclusion volume.
In vitro C3 attachment. In order to coat human red cells in vitro with C3, serum containing cold agglutinin diluted in VBS was mixed with washed red cells in standard suspension and fresh compatible human serum as a source of complement. The mixture was incubated at 00C for 15 min, then at 370C for 45 min. The cells were sedimented by centrifugation at 37°C and the supernatant fluid was analyzed for the presence of hemoglobin by measuring optical density at 412 nm. The cells (EC3) were washed twice with 0.015 M EDTA at 37'C, then thrice with VBS at 370C and resuspended to the standard cell concentration in 60% sucrose buffer.
C1 fixation and transfer. The amount of CT fixed by anti-C3 to C3-coated red cells was determined by a modification of the Cl fixation and transfer test (18) . Cells coated with C3 (EC3) in a suspension containing 2.2 X 107 in 0.1 ml,. were mixed with 0.1 ml of anti-C3 and 0.2 ml functionally pure C1, containing at least 10" hemolytically active molecules per ml (19) . After 60 min, the excess Cl was removed by washing with 60% isotonic sucrose-40% VBS buffer. The amount of Cl fixed was determined by the method of Borsos and Rapp (5) . When membranebound C3 was estimated repeatedly on the same sample of EC3 by this method, the amount of Cl fixed varied from the mean by less than 12% in all instances.
In order to ascertain the concentration of anti-C3 which fixed the greatest amount of Cl to EC3 cells, two sets of EC3 cells, one of which had been reacted with cold agglutinin and a high concentration of serum as a source of complement ("high EC3") and the other with the same amount of cold agglutinin and a lower concentration of fresh serum ("low EC3"), were reacted with varying dilutions of anti-C3. The amount of C3 fixed to these EC3 cells by varying amounts of anti-C3 is shown in Fig. 1 . For the cells heavily coated with C3, the same number of molecules of C1 were fixed with dilutions of anti-C3 from 1: 40 to 1: 320. For "low EC3" cells, the maximum amount of C1 was fixed at a 1: 50 dilution of anti-C3. This dilution was used in all studies unless otherwise stated. arm. 3,000 ml of plasma were removed in 4 h with a 70% fall in cold agglutinin level, as measured by ability of the cold agglutinin and fresh serum to lyse the red cells of patients with paroxysmal nocturnal hemoglobinuria (PNH) (20, 21) . Within 1 week the antibody titer, as measured by the hemolytic assay, returned to the levels seen before plasmapheresis. The rate of endogenous CO production (22) fell following plasmapheresis, indicating that the hemolytic rate decreased; CO production increased as the plasma antibody concentration subsequently rose. The amount of cell-bound C3 detected by anti-C3 and the C1 fixation and the transfer technique did not change appreciably after plasmapheresis or during the following week (Fig. 6 ).
The effect of addition of C3 to transfused normal cells. To determine the effect of addition of C3 to normal cells in the absence of cold stress, patient J. C., whose red cells were type B, was transfused with 2 U of type 0 packed cells which were warmed at 370C prior to transfusion. A portion of the cells used in the transfusion was labeled with chromium-51 and was injected at the end of the transfusion. The survival of these labeled cells was followed by serial samples over the next 48 h (23) . the first 24 h without accelerated destruction of the transfused cells.
The effect of acute changes in cell-bound C3 produced by cold. To determine the effect of cold stress on the amount of cell-bound C3 and its relationship to hemolysis, one arm of patient J. C. was immersed in water at 80C for 1.5 min. At intervals of time, samples were lrawn from this arm and from the uncooled arm, and the amount of red cell-bound C3 and the plasma hemoglobin (24) were determined (see Fig. 8 ). After removing the arm from cold water, both red cell-bound C3 and plasma hemoglobin rapidly increased; these measures did not change in the uncooled arm. After 20 min, the red cellbound C3 and the plasma hemoglobin in both arms was the same as control values. The effect of cold stress on patient C. T. was tested in the same manner, and qualitatively identical results were obtained (see Table III arm were withdrawn at intervals, after rewarming. The rate of hemolysis was estimated by the endogenous CO method (22) immediately after the patient re-entered a warm room. This was compared with the rate of endogenous CO production prior to cold exposure. Cellbound C3, plasma hemoglobin, and endogenous CO production rose, as shown in Table III , indicating hemolysis associated with rapid accumulation of membranebound C3. DISCUSSION The role of membrane-bound C3 in the production of hemolytic anemia of patients with the cold agglutinin syndrome is controversial (3, 25) . C3 is known to exist on the membrane in hemolytically active and inactive forms. There is some evidence that the antigenic determinants present in the inactive form are different than those present in the active form. This assay measures total membrane-bound C3, including both hemolyticallv active and inactive forms.
In the absence of cold stress, most of the membranebound C3 is apparently hemolytically inactive. The amount of cell-bound C3 detected was unchanged while large variations in cold agglutinin concentration and in hemolytic rate were produced by plasmapheresis (patient J. C. On the other hand, acute cold stress causes rapid increase in detectable membrane-bound C3 and immediate hemolysis. The rate of increase of cell-bound C3 was much greater in the cold-arm experiment than in the transfusion studies, although the total amount of C3 added per red cell was less. The relationship between the rapid accumulation of membrane-bound C3 and immediate hemolysis was also confirmed in the cold stress experiments with patients C. T. and C. P. Red cell destruction correlated with the rate of accumulation of C3 rather than the absolute amount of C3 added in vivo in these studies. Thus, some of the C3 is in a hemolytically active form when added rapidly to the membrane, while that membrane-bound C3 which is detectable without cold stress is almost entirely inactive.
The presence in serum of an inactivator of membranebound C3 may account for the dependence of hemolytic activity upon the rate of attachment of C3 to the red cell (28, 29) and for the accumulation of large amounts of "inactive" membrane-bound C3. This inactivator (C3bINA) causes the loss of hemolytic activity and of immune adherence reactivity of membrane-bound C3. C3bINA presumably cleaves the activated C3 molecule to smaller fragments which may have different antigenic determinants (3). These C3 fragments cannot propagate the complement sequence, but are detectable by anti-C3.
The methods used to quantitate red cell destruction in these studies could not differentiate between complementmediated hemolysis and red cell destruction produced by direct agglutination. Lewis, Dacie, and Szur have suggested that cold agglutinin-induced aggregation does not cause red cell damage which persists after the antibody is disassociated from the cell (6) . The thermal amplitude of the antibody might be important in determining red cell destruction, either by aggregation or by complement fixation. The cold agglutinin of patient J. C. appears to have a thermal amplitude similar to that of the cold agglutinins of other patients.
C3 accumulation on red cells in vivo in patients with the cold agglutinin syndrome appears to be the result of a complex series of interactions. Human red cells are resistant to direct lysis by the completion of complement sequences but a large amount of C3 molecules are attached to the membrane (16) . This C3 is probably inactivated by C3bINA, resulting in large amounts of "inactive" C3 fragments on circulating cells. In the absence of cold stress, inactivation of membrane-bound C3 occurs before sufficient active C3 accumulates to propagate the complement sequence to a hemolytic conclusion.
With acute cold stress, C3 is attached to the membrane rapidly and its inactivation by C3bINA does not proceed quickly enough to prevent propagation of the complement sequence to completion, resulting in hemolysis.
